1. Different Mechanisms Are Utilized by Coronavirus Transmissible Gastroenteritis Virus To Regulate Interferon Lambda 1 and Interferon Lambda 3 Production.
- Author
-
Mei Xue, Wenzhe Wang, Haojie He, Liang Li, Xin Zhang, Hongyan Shi, Pinghuang Liu, and Li Feng
- Subjects
- *
TYPE I interferons , *GASTROENTERITIS , *INTERFERONS , *CORONAVIRUS diseases , *COVID-19 , *COVID-19 pandemic , *INTESTINAL injuries , *PLANT viruses - Abstract
Type III interferons (IFN-λ) are shown to be preferentially produced by epithelial cells, which provide front-λine protection at barrier surfaces. Transmissible gastroenteritis virus (TGEV), belonging to the genus Alphacoronavirus of the family Coronaviridae, can cause severe intestinal injuries in porcine, resulting in enormous economic losses for the swine industry, worldwide. Here, we demonstrated that although IFN-λ1 had a higher basal expression, TGEV infection induced more intense IFN-λ3 production in vitro and in vivo than did IFN-λ1. We explored the underlying mechanism of IFN-λ induction by TGEV and found a distinct regulation mechanism of IFN-λ1 and IFN-λ3. The classical RIGI- like receptor (RLR) pathway is involved in IFN-λ3 but not IFN-λ1 production. Except for the signaling pathways mediated by RIG-I and MDA5, TGEV nsp1 induces IFN-λ1 and IFN-λ3 by activating NF-k B via the unfolded protein responses (UPR) PERK-eIF2a pathway. Furthermore, functional domain analysis indicated that the induction of IFN-λ by the TGEV nsp1 protein was located at amino acids 85 to 102 and was dependent on the phosphorylation of eIF2a and the nuclear translocation of NF-k B. Moreover, the recombinant TGEV with the altered amino acid motif of nsp1 85-102 was constructed, and the nsp1 (85-102sg) mutant virus significantly reduced the production of IFN-λ, compared with the wild strain. Compared to the antiviral activities of IFN-λ1, the administration of IFN-λ3 showed greater antiviral activity against TGEV infections in IPEC-J2 cells. In summary, our data point to the significant role of IFN-λ in the host innate antiviral responses to coronavirus infections within mucosal organs and in the distinct mechanisms of IFN-λ1 and IFN-λ3 regulation. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF